Cures Within Reach’s mission is to leverage the speed, safety and cost-effectiveness of repurposing, testing already approved therapies for new diseases: driving more treatments to more patients more quickly.

Our focus: providing seed funds for proof-of-concept or pivotal studies that, when successful, allow a catalytic effect of follow-on funding for trials that build clinical evidence for regulatory approval or for off-label use.

Our 2023 Annual Report is available here.

Read about our newest success story in tuberculosis and our new organizational records achieved during 2023:

  • $16 million in follow-on funding raised by our researchers
  • 16 clinical trials started
  • 10 clinical trials completed


Read our January 2024 news release announcing our newest success story in tuberculosis, our new funding partner for LMICs and the 4 LMIC-based clinical trials selected in 2023.


Learn about our 2024 initiatives: 

in Pediatrics

for Veterans/Military

and for Underrepresented Patients and Researchers.

clinical research for unsolved diseases

Diseases Researched

repurposing research grants funding

Repurposing Trials Funded


Institutions Funded


Success Stories


Startups with CWR Investments


Companies Commercializing CWR Projects


Millions of Dollars in Project Funding

repurposing-research-initiated -follow-on-funding supporting clinical research

Millions of Dollars in Follow-on Funding Leveraged